In the largest population-based retrospective study on combination therapies for high-risk prostate cancer, a team led by Grace Lu-Yao, PhD, MPH, professor and vice chair of medical oncology, found that more patients live longer if treated with prostate removal (prostatectomy) plus radiation therapy. The study was the first to show that removing the whole prostate and following up with radiation therapy is associated with greater overall survival than simply treating the prostate with radiation plus hormone-blocking therapy.
"Real World Data Review Sheds Light on Medical Treatment,"
Thomas Jefferson University Research Magazine: Vol. 1:
1, Article 4.
Available at: https://jdc.jefferson.edu/researchmagazine/vol1/iss1/4